Mass spectrometry-based plasma proteomics: state of the art and future outlook.
about
Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence.Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.Technical Advances of the Recombinant Antibody Microarray Technology Platform for Clinical ImmunoproteomicsComprehensive and quantitative proteomic analyses of zebrafish plasma reveals conserved protein profiles between genders and between zebrafish and human.Techniques and Approaches to Genetic Analyses in Nephrological Disorders.Human immune system variationSample preparation strategies for targeted proteomics via proteotypic peptides in human blood using liquid chromatography tandem mass spectrometry.Recent applications of CE- and HPLC-MS in the analysis of human fluids.SWATH Mass Spectrometry for Proteomics of Non-Depleted Plasma.Temporal profiles of plasma proteome during childhood development.The Proteomic Characterization of Plasma or Serum from HIV-Infected Patients.A differential protein solubility approach for the depletion of highly abundant proteins in plasma using ammonium sulfate.A plasma proteomics method reveals links between ischemic stroke and MTHFR C677T genotype.Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression.Discovery of a Potential Plasma Protein Biomarker Panel for Acute-on-Chronic Liver Failure Induced by Hepatitis B Virus.Polymeric ionic liquid-assembled graphene-immobilized silica composite for selective isolation of human serum albumin from human whole blood.Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling.Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry.
P2860
Q33599603-E39DE24C-F530-4C3E-ABC4-23DB3C07E134Q36040379-46F7BDAB-668F-4A00-BCD4-C8695107ACCFQ36077087-0E7C5307-DDD0-4CB4-9D09-F7FC0439B8FAQ36793159-D4C1B5DA-9013-4471-9104-5EB9FDC68E29Q37032666-B1482974-BC6E-4B42-A535-1222ED329510Q37669442-3601D542-ABC2-421D-AF56-CB3420EAE9C8Q38270732-75B21872-ACD2-4334-9949-2E6F9734AF92Q38596722-61018A1F-0799-4BC6-9B2C-C86BA4A7F6D6Q38694922-37004F4A-9697-47BF-B194-E89B458FAF81Q39150450-020D536D-8B06-4A1D-B8A8-10A69CA99D88Q40852728-7C57CCED-9517-47FD-A95F-6CA4342B37C6Q41146985-80970E93-4FDE-41B0-94E1-19FF278FE384Q42683413-750ECAE9-D59B-40CC-9083-9A5494E8C168Q46290391-1C34D214-4AC5-4810-93D4-A5D6EDB4A571Q47158621-BDA21370-B90B-4EE2-A6B3-08834AB6007DQ47353763-7DDBD68F-C332-4D76-A60E-0035BDAF625EQ47421750-3660A089-BBAE-4040-A211-A06C7922CE67Q48021398-3A4A7D81-8DC0-4392-BAB5-5DBC8E649F2E
P2860
Mass spectrometry-based plasma proteomics: state of the art and future outlook.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mass spectrometry-based plasma proteomics: state of the art and future outlook.
@en
type
label
Mass spectrometry-based plasma proteomics: state of the art and future outlook.
@en
prefLabel
Mass spectrometry-based plasma proteomics: state of the art and future outlook.
@en
P2860
P1476
Mass spectrometry-based plasma proteomics: state of the art and future outlook.
@en
P2860
P304
P356
10.1586/14789450.2014.901157
P577
2014-03-24T00:00:00Z